The DOI matches its Crossref record; 261 of the 261 references it cites were found in a registry or an index.
British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis
Open accessAbstract
Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease which, if untreated, often leads to cirrhosis, liver failure and death. Major advances were made in its management based on controlled trials performed in England and the USA in the 1970s and 1980s. Unfortunately, in recent decades there has been a dearth of controlled clinical trials and, thus, many questions regarding the optimal management of this disease remain unanswered. Many promising newer immunosuppressive therapies await formal comparison with standard therapies and also many important details in relation to the application of standard therapies remain unclear. These guidelines describe the optimal management strategies in adults based on available published evidence, including the American Association for the Study of Liver Diseases practice guidelines for the diagnosis and treatment of AIH published in 2002 and recently updated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Histological grading and staging of chronic hepatitis
Ishak, K., Baptista, A., Bianchi, L., Callea, F., De Groote, J., Gudat, F., Denk, H., Desmet, V., Korb, G., MacSween, R. N. M., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,029
Alvarez, F., Berg, P. A., Bianchi, F. B., Bianchi, L., Burroughs, A. K., Cancado, E. L., Chapman, R. W., Cooksley, W. G. E., Czaja, A. J., Desmet, V. J., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80297-9 · Cited by 2,903
D'Amico, G., Garcia-Tsao, G., & Pagliaro, L. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.013 · Cited by 2,687
Classification of chronic hepatitis: Diagnosis, grading and staging
Desmet, V. J., Gerber, M., Hoofnagle, J. H., Manns, M., & Scheuer, P. J. (1994) · Hepatology · doi:10.1002/hep.1840190629 · Cited by 2,593
Simplified criteria for the diagnosis of autoimmune hepatitis
Hennes, E. M., Zeniya, M., Czaja, A. J., Parés, A., Dalekos, G. N., Krawitt, E. L., Bittencourt, P. L., Porta, G., Boberg, K. M., Hofer, H., et al. (2008) · Hepatology · doi:10.1002/hep.22322 · Cited by 1,901
Diagnosis and management of autoimmune hepatitis
Manns, M. P., Czaja, A. J., Gorham, J. D., Krawitt, E. L., Mieli-Vergani, G., Vergani, D., & Vierling, J. M. (2010) · Hepatology · doi:10.1002/hep.23584 · Cited by 1,442
Meeting report: International autoimmune hepatitis group
Johnson, P. J., & McFarlane, I. G. (1993) · Hepatology · doi:10.1002/hep.1840180435 · Cited by 1,090
Soloway, R. D., Summerskill, W. H. J., Baggenstoss, A. H., Geall, M. G., Gitnick, G. L., Elveback, L. R., & Schoenfield, L. J. (1972) · Gastroenterology · doi:10.1016/s0016-5085(19)33223-8 · Cited by 779
Chazouillères, O., Wendum, D., Serfaty, L., Montembault, S., Rosmorduc, O., & Poupon, R. (1998) · Hepatology · doi:10.1002/hep.510280203 · Cited by 746
Gregorio, G. (2001) · Hepatology · doi:10.1053/jhep.2001.22131 · Cited by 692
The clinical pharmacology of 6-mercaptopurine
Lennard, L. (1992) · European Journal of Clinical Pharmacology · doi:10.1007/bf02220605 · Cited by 647
Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis
Wies, I., Brunner, S., Henninger, J., Herkel, J., Kanzler, S., zum Büschenfelde, K.-H. M., & Lohse, A. W. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02166-8 · Cited by 636
Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic Hepatitis
COOK, G. C., MULLIGAN, R., & SHERLOCK, S. (1971) · QJM · doi:10.1093/oxfordjournals.qjmed.a067264 · Cited by 564
Diagnosis and treatment of autoimmune hepatitis
Czaja, A. J., & Freese, D. K. (2002) · Hepatology · doi:10.1053/jhep.2002.34944 · Cited by 563
Boberg, K. M., Chapman, R. W., Hirschfield, G. M., Lohse, A. W., Manns, M. P., & Schrumpf, E. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.09.002 · Cited by 555 · cited 2×
“Indeed, it may be more useful to characterise patients with autoimmune liver disease according to the predominant ‘primary’ disease and not to regard ‘overlap’ syndromes as separate entities.(76) Using the revised IAIHG criteria,(103) 19% of patients with PBC had probable AIH but none had definite AIH.”
BackgroundK. M. BOBERG, E. A. (1998) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365529850166284 · Cited by 517
Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome †
Wiesner, R. H., Demetris, J. A., Belle, S. H., Seaberg, E. C., Lake, J. R., Zetterman, R. K., Everhart, J., & Detre, K. M. (1998) · Hepatology · doi:10.1002/hep.510280306 · Cited by 495
Dubinsky, M. C., Yang, H., Hassard, P. V., Seidman, E. G., Kam, L. Y., Abreu, M. T., Targan, S. R., & Vasiliauskas, E. A. (2002) · Gastroenterology · doi:10.1053/gast.2002.32420 · Cited by 483
CONTROLLED TRIAL OF PREDNISONE AND AZATHIOPRINE IN ACTIVE CHRONIC HEPATITIS
Murray-Lyon, I., Stern, R. B., & Williams, R. (1973) · The Lancet · doi:10.1016/s0140-6736(73)92125-9 · Cited by 468
Manns, M. P., Griffin, K. J., Sullivan, K. F., & Johnson, E. F. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115443 · Cited by 456
Vergani, D., Alvarez, F., Bianchi, F. B., Cançado, E. L. R., Mackay, I. R., Manns, M. P., Nishioka, M., & Penner, E. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.08.002 · Cited by 446
Manns, M. P., Woynarowski, M., Kreisel, W., Lurie, Y., Rust, C., Zuckerman, E., Bahr, M. J., Günther, R., Hultcrantz, R. W., Spengler, U., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.046 · Cited by 442
Drug-induced autoimmune hepatitis: clinical characteristics and prognosis
Björnsson, E., Talwalkar, J., Treeprasertsuk, S., Kamath, P. S., Takahashi, N., Sanderson, S., Neuhauser, M., & Lindor, K. (2010) · Hepatology · doi:10.1002/hep.23588 · Cited by 436
Manns, M., Kyriatsoulis, A., Gerken, G., Staritz, M., Meyer, K. H., & Büschenfelde, Z. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92024-1 · Cited by 424
De-novo autoimmune hepatitis after liver transplantation
Kerkar, N., Hadzic, N., Davies, E. T., Portmann, B., Donaldson, P. T., Rela, M., Heaton, N. D., Vergani, D., & Mieli-Vergani, G. (1998) · The Lancet · doi:10.1016/s0140-6736(97)06478-7 · Cited by 413
Roberts, M. S., Angus, D. C., Bryce, C. L., Valenta, Z., & Weissfeld, L. (2004) · Liver Transplantation · doi:10.1002/lt.20137 · Cited by 383
Azathioprine for Long-Term Maintenance of Remission in Autoimmune Hepatitis
Johnson, P. J., McFarlane, I. G., & Williams, R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510123331502 · Cited by 382
Autoimmune Hepatitis: Effect of Symptoms and Cirrhosis on Natural History and Outcome *
Feld, J. J., Dinh, H., Arenovich, T., Marcus, V. A., Wanless, I. R., & Heathcote, J. E. (2005) · Hepatology · doi:10.1002/hep.20732 · Cited by 367
Liver biopsy interpretation for causes of late liver allograft dysfunction
(2006) · Hepatology · doi:10.1002/hep.21280 · Cited by 359
Summerskill, W. H., Korman, M. G., Ammon, H. V., & Baggenstoss, A. H. (1975) · Gut · doi:10.1136/gut.16.11.876 · Cited by 352
Francella, A., Dyan, A., Bodian, C., Rubin, P., Chapman, M., & Present, D. H. (2003) · Gastroenterology · doi:10.1053/gast.2003.50014 · Cited by 331
Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis
Czaja, A. J., & Carpenter, H. A. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)91081-r · Cited by 324
Celiac disease in patients with severe liver disease: Gluten-free diet may reverse hepatic failure
Kaukinen, K., Halme, L., Collin, P., Färkkilä, M., Mäki, M., Vehmanen, P., Partanen, J., & Höckerstedt, K. (2002) · Gastroenterology · doi:10.1053/gast.2002.32416 · Cited by 304
Prognosis of histological cirrhosis in type 1 autoimmune hepatitis
Roberts, S., Therneau, T., & Czaja, A. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8608895 · Cited by 299
Kirk, A. P., Jain, S., Pocock, S., Thomas, H. C., & Sherlock, S. (1980) · Gut · doi:10.1136/gut.21.1.78 · Cited by 285
Lohse, A. W., zum Büschenfelde, K.-H. M., Franz, B., Kanzler, S., Gerken, G., & Dienes, H.-P. (1999) · Hepatology · doi:10.1002/hep.510290409 · Cited by 278
Silman, A. J., Petrie, J., Hazleman, B., & Evans, S. J. (1988) · Annals of the Rheumatic Diseases · doi:10.1136/ard.47.12.988 · Cited by 276
Recurrence of autoimmune liver disease after liver transplantation: A systematic review
Gautam, M., Cheruvattath, R., & Balan, V. (2006) · Liver Transplantation · doi:10.1002/lt.20910 · Cited by 274
Ma, Y., Okamoto, M., Thomas, M. G., Bogdanos, D. P., Lopes, A. R., Portmann, B., Underhill, J., Dürr, R., Mieli-Vergani, G., & Vergani, D. (2002) · Hepatology · doi:10.1053/jhep.2002.32092 · Cited by 271
Primary Sclerosing Cholangitis in Children: A Long–Term Follow–Up Study
Feldstein, A. E., Perrault, J., El-Youssif, M., Lindor, K. D., Freese, D. K., & Angulo, P. (2003) · Hepatology · doi:10.1053/jhep.2003.50289 · Cited by 256
Management and outcome of pregnancy in autoimmune hepatitis
Heneghan, M. A., Norris, S. M., O'Grady, J. G., Harrison, P. M., & McFarlane, I. G. (2001) · Gut · doi:10.1136/gut.48.1.97 · Cited by 253
Self-citationIchai, P., Duclos-Vallée, J.-C., Guettier, C., Hamida, S. B., Antonini, T., Delvart, V., Saliba, F., Azoulay, D., Castaing, D., & Samuel, D. (2007) · Liver Transplantation · doi:10.1002/lt.21036 · Cited by 249
Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis
Czaja, A. J., & Carpenter, H. A. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.01.009 · Cited by 248
Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: A nationwide study
Werner, M., Prytz, H., Ohlsson, B., Almer, S., Björnsson, E., Bergquist, A., Wallerstedt, S., Sandberg-Gertzén, H., Hultcrantz, R., Sangfelt, P., et al. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802130183 · Cited by 243
Bone disorders in chronic liver disease
Collier, J. (2007) · Hepatology · doi:10.1002/hep.21852 · Cited by 238
AGA technical review on osteoporosis in hepatic disorders
LESLIE, W. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01062-x · Cited by 232
Pregnancy in Autoimmune Hepatitis: Outcome and Risk Factors
Schramm, C., Herkel, J., Beuers, U., Kanzler, S., Galle, P. R., & Lohse, A. W. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00479.x · Cited by 228
Short-term cyclosporine induces a remission of autoimmune hepatitis in children
Alvarez, F., Ciocca, M., Cañero-Velasco, C., Ramonet, M., Davila, M. T. G. D., Cuarterolo, M., Gonzalez, T., Jara-Vega, P., Camarena, C., Brochu, P., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80065-8 · Cited by 227
Performance parameters of the diagnostic scoring systems for autoimmune hepatitis
Czaja, A. J. (2008) · Hepatology · doi:10.1002/hep.22513 · Cited by 221
Aetiopathogenesis of autoimmune hepatitis
Longhi, M. S., Ma, Y., Mieli-Vergani, G., & Vergani, D. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.08.010 · Cited by 220
Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis
Kessler, W. R., Cummings, O. W., Eckert, G., Chalasani, N., Lumeng, L., & Kwo, P. Y. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00246-0 · Cited by 216
Autoimmune liver serology: Current diagnostic and clinical challenges
Bogdanos, D. P., Invernizzi, P., Mackay, I. R., & Vergani, D. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3374 · Cited by 213
Current and novel immunosuppressive therapy for autoimmune hepatitis
Heneghan, M. A., & McFarlane, I. G. (2002) · Hepatology · doi:10.1053/jhep.2002.30991 · Cited by 210
Self-citationKerkar, N., Choudhuri, K., Ma, Y., Mahmoud, A., Bogdanos, D. P., Muratori, L., Bianchi, F., Williams, R., Mieli-Vergani, G., & Vergani, D. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1481 · Cited by 208
Al-Chalabi, T., Boccato, S., Portmann, B. C., McFarlane, I. G., & Heneghan, M. A. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.04.007 · Cited by 208
Self-citationLong-term Outcomes of Patients With Autoimmune Hepatitis Managed at a Nontransplant Center
Hoeroldt, B., McFarlane, E., Dube, A., Basumani, P., Karajeh, M., Campbell, M. J., & Gleeson, D. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.065 · Cited by 207
Self-citationAdams, L. A., Lindor, K. D., & Angulo, P. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30444.x · Cited by 207
Boberg, K. M., Fausa, O., Haaland, T., Holter, E., Mellbye, O. J., Spurkland, A., & Schrumpf, E. (1996) · Hepatology · doi:10.1002/hep.510230612 · Cited by 205
Richardson, P. D., James, P. D., & Ryder, S. D. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80271-8 · Cited by 204
High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis
Targan, S. R., Landers, C., Vidrich, A., & Czaja, A. J. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90215-5 · Cited by 199
HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients
Seki, T., Ota, M., Furuta, S., Fukushima, H., Kondo, T., Hino, K., Mizuki, N., Ando, A., Tsuji, K., Inoko, H., et al. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90041-v · Cited by 198
Verma, S., Gunuwan, B., Mendler, M., Govindrajan, S., & Redeker, A. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30457.x · Cited by 196
Chazouillères, O., Wendum, D., Serfaty, L., Rosmorduc, O., & Poupon, R. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.017 · Cited by 194
Kaya, M., Angulo, P., & Lindor, K. D. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80004-5 · Cited by 193
Autoimmune hepatitis with incidental histologic features of bile duct injury
Czaja, A. J., & Carpenter, H. A. (2001) · Hepatology · doi:10.1053/jhep.2001.27562 · Cited by 189
RECURRENCE OF AUTOIMMUNE HEPATITIS AFTER LIVER TRANSPLANTATION1,2
Milkiewicz, P., Hubscher, S. G., Skiba, G., Hathaway, M., & Elias, E. (1999) · Transplantation · doi:10.1097/00007890-199907270-00016 · Cited by 189
High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis
van Buuren, H. R., van Hoogstraten, H. J. F., Terkivatan, T., Schalm, S. W., & Vleggaar, F. P. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80005-7 · Cited by 189
Mycophenolate Mofetil as Second Line Therapy in Autoimmune Hepatitis?
Hennes, E. M., Oo, Y. H., Schramm, C., Denzer, U., Buggisch, P., Wiegard, C., Kanzler, S., Schuchmann, M., Boecher, W., Galle, P. R., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02180.x · Cited by 188
Ratziu, V., Samuel, D., Sebagh, M., Farges, O., Saliba, F., Ichai, P., Farahmand, H., Gigou, M., Féray, C., Reynès, M., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80017-8 · Cited by 188
Zachou, K., Gatselis, N., Papadamou, G., Rigopoulou, E. I., & Dalekos, G. N. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.12.032 · Cited by 186
Treatment options for autoimmune hepatitis: A systematic review of randomized controlled trials
Lamers, M. M. H., van Oijen, M. G. H., Pronk, M., & Drenth, J. P. H. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.01.037 · Cited by 185
Baeres, M., Herkel, J., Czaja, A. J., Wies, I., Kanzler, S., Cancado, E. L. R., Porta, G., Nishioka, M., Simon, T., Daehnrich, C., et al. (2002) · Gut · doi:10.1136/gut.51.2.259 · Cited by 184
Thiel, D. H. V., Wright, H. I., Carroll, P. B., Abu-Elmagd, K. M., Rodriguez-Rilo, H. L., McMichael, J., Irish, W. D., & Starzl, T. E. (1995) · PubMed · Cited by 183
Baggenstoss, A. H., Soloway, R. D., Summerskill, W. H. J., Elveback, L. R., & Schoenfield, L. J. (1972) · Human Pathology · doi:10.1016/s0046-8177(72)80072-8 · Cited by 183
Yeoman, A. D., Al-Chalabi, T., Karani, J. B., Quaglia, A., Devlin, J., Mieli-Vergani, G., Bomford, A., O'Grady, J. G., Harrison, P. M., & Heneghan, M. A. (2008) · Hepatology · doi:10.1002/hep.22432 · Cited by 183
Self-citationSanchez-Urdazpal, L., Czaja, A. J., van Hoek, B., Krom, R. A. F., & Wiesner, R. H. (1992) · Hepatology · doi:10.1002/hep.1840150208 · Cited by 183
The nature and prognostic implications of autoimmune hepatitis with an acute presentation
Nikias, G. A., Batts, K. P., & Czaja, A. J. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(94)80251-3 · Cited by 182
Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery
Buchel, E. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)05541-7 · Cited by 181
Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis
Al-Chalabi, T., Underhill, J. A., Portmann, B. C., McFarlane, I. G., & Heneghan, M. A. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.08.013 · Cited by 181
Self-citationBehavior and significance of autoantibodies in type 1 autoimmune hepatitis
Czaja, A. J. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80096-8 · Cited by 180
Yeoman, A. D., Westbrook, R. H., Al‐Chalabi, T., Carey, I., Heaton, N. D., Portmann, B. C., & Heneghan, M. A. (2009) · Hepatology · doi:10.1002/hep.23042 · Cited by 177
Self-citationLiver transplantation for autoimmune hepatitis
Reich, D. J., Fiel, I., Guarrera, J. V., Emre, S., Guy, S. R., Schwartz, M. E., Miller, C. M., & Sheiner, P. A. (2000) · Hepatology · doi:10.1053/jhep.2000.16666 · Cited by 176
Joshi, S., Cauch-Dudek, K., Wanless, I. R., Lindor, K. D., Jorgensen, R., Batts, K., & Heathcote, J. E. (2002) · Hepatology · doi:10.1053/jhep.2002.30902 · Cited by 174 · cited 1×
“Joshi et al described histological improvement on UDCA treatment alone in three of nine patients but the histology worsened in two other patients.(300) In other reports liver tests did not improve on UDCA alone but, following treatment with prednisolone, most patients achieve biochemical remission and serial biopsies…”
BackgroundRelapse Following Treatment Withdrawal in Patients with Autoimmune Chronic Active Hepatitis
Hegarty, J. E., Nouri Aria, K. T., Portmann, B., Eddleston, A. L. W. F., & Williams, R. (1983) · Hepatology · doi:10.1002/hep.1840030510 · Cited by 174
Czaja, A. J., Menon, N. K. V., & Carpenter, H. A. (2002) · Hepatology · doi:10.1053/jhep.2002.32485 · Cited by 171
Chronic Active Hepatitis and Severe Hepatic Necrosis Associated with Nitrofurantoin
SHARP, J. R., ISHAK, K. G., & ZIMMERMAN, H. J. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-1-14 · Cited by 171
Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis
Poupon, R., Chazouilleres, O., Corpechot, C., & Chrétien, Y. (2006) · Hepatology · doi:10.1002/hep.21229 · Cited by 170 · cited 1×
“In about 4% of cases AIH follows the onset of PBC, sometimes by many years, and in 2% PBC followed AIH.(297) Patients with AIH/PBC overlap have a high prevalence of HLA B8, not Bs DR3 and DR4, more typical of patients with AIH than with PBC.”
BackgroundMontano-Loza, A. J., Carpenter, H. A., & Czaja, A. J. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01153.x · Cited by 170
Christopher, V., Al-Chalabi, T., Richardson, P. D., Muiesan, P., Rela, M., Heaton, N. D., O'Grady, J. G., & Heneghan, M. A. (2006) · Liver Transplantation · doi:10.1002/lt.20810 · Cited by 170
Self-citationPerdigoto, R., Carpenter, H. A., & Czaja, A. J. (1992) · Journal of Hepatology · doi:10.1016/0168-8278(92)90178-r · Cited by 168
Overlap of Autoimmune Hepatitis and Primary Biliary Cirrhosis: Long-Term Outcomes
Silveira, M. G., Talwalkar, J. A., Angulo, P., & Lindor, K. D. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01136.x · Cited by 165
Genetics of liver disease: immunogenetics and disease pathogenesis
Donaldson, P. T. (2004) · Gut · doi:10.1136/gut.2003.031732 · Cited by 164
Czaja, A. J., Davis, G. L., Ludwig, J., & Taswell, H. F. (1984) · Hepatology · doi:10.1002/hep.1840040409 · Cited by 163
Serologic Markers Compared With Liver Biopsy for Monitoring Disease Activity in Autoimmune Hepatitis
Lüth, S., Herkel, J., Kanzler, S., Frenzel, C., Galle, P. R., Dienes, H. P., Schramm, C., & Lohse, A. W. (2008) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318154af74 · Cited by 161
RECURRENCE OF AUTOIMMUNE CHRONIC ACTIVE HEPATITIS FOLLOWING ORTHOTOPIC LIVER GRAFTING
NEUBERGER, J., PORTMANN, B., CALNE, R., & WILLIAMS, R. (1984) · Transplantation · doi:10.1097/00007890-198404000-00009 · Cited by 160
Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults
Heneghan, M. A., Portmann, B. C., Norris, S. M., Williams, R. L., Muiesan, P., Rela, M., Heaton, N. D., & O’Grady, J. G. (2001) · Hepatology · doi:10.1053/jhep.2001.26756 · Cited by 156
Self-citationThe causes of obvious jaundice in South West Wales: perceptions versus reality
Whitehead, M. W. (2001) · Gut · doi:10.1136/gut.48.3.409 · Cited by 155
OUTCOME OF AUTOIMMUNE HEPATITIS AFTER LIVER TRANSPLANTATION1
Prados, E., Cuervas‐Mons, V., de la Mata, M., Fraga, E., Rimola, A., Prieto, M. N., Clemente, G., Vicente, E., Casanovas, T., & Fábrega, E. (1998) · Transplantation · doi:10.1097/00007890-199812270-00013 · Cited by 154
Stricker, B. H. C., BLOK, R. A. P. R., Claas, F. H. J., Parys, G. V., & Desmet, V. J. (1988) · Hepatology · doi:10.1002/hep.1840080327 · Cited by 154
Pathogenesis of autoimmune hepatitis
Vergani, D., Choudhuri, K., Bogdanos, D. P., & Mieli‐Vergani, G. (2002) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00018-1 · Cited by 153
Al‐Chalabi, T., Portmann, B. C., Bernal, W., McFarlane, I. G., & Heneghan, M. A. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03722.x · Cited by 152
Self-citationAutoimmune hepatitis in Italy: The Bologna experience
Muratori, P., Granito, A., Quarneti, C., Ferri, S., Menichella, R., Cassani, F., Παππάς, Γ., Bianchi, F. B., Lenzi, M., & Muratori, L. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.01.020 · Cited by 151
Montaño‐Loza, A. J., Carpenter, H. A., & Czaja, A. J. (2007) · Hepatology · doi:10.1002/hep.21787 · Cited by 150
Kaskas, B., Louis, E., Hindorf, U., Schaeffeler, E., Deflandre, J., Graepler, F., Schmiegelow, K., Gregor, M., Zanger, U. M., Eichelbaum, M., et al. (2002) · Gut · doi:10.1136/gut.52.1.140 · Cited by 150
Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis
Kanzler, S., Weidemann, C., Gerken, G., Löhr, H. F., Galle, P. R., Büschenfelde, K. M. Z., & Lohse, A. W. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80342-0 · Cited by 149
Czaja, A. J. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328034f234 · Cited by 149
Long‐term outcome of liver transplantation for autoimmune hepatitis
Vogel, A., Heinrich, E., Bahr, M. J., Rifai, K., Flemming, P., Melter, M., Klempnauer, J., Nashan, B., Manns, M. P., & Strassburg, C. P. (2004) · Clinical Transplantation · doi:10.1111/j.1399-0012.2004.00117.x · Cited by 147
Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis
O'Brien, C., Joshi, S., Feld, J. J., Guindi, M., Dienes, H. P., & Heathcote, E. J. (2008) · Hepatology · doi:10.1002/hep.22380 · Cited by 146 · cited 1×
“For example, 8% of patients with otherwise typical AIH have destructive bile duct lesions considered characteristic of PBC,(146) 147 and in 8e12% of patients the serum is positive for antimitochondrial antibody.(121) 122 The prevalence of ‘overlap’dthat is, both AIH and PBC in the same patientddepends critically on ho…”
BackgroundLong-term management and prognosis of autoimmune hepatitis (AIH): A single center experience
Kanzler, S., Löhr, H. F., Gerken, G., Galle, P. R., & Lohse, A. W. (2001) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2001-13708 · Cited by 145
Hay, E. J., Czaja, A. J., Rakela, J., & Ludwig, J. (1989) · Hepatology · doi:10.1002/hep.1840090205 · Cited by 145
High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitisNote
van Buuren, H. R., van Hoogstraten, H. J. F., Terkivatan, T., Schalm, S. W., & Vleggaar, F. P. (2000) · Journal of Hepatology · doi:10.1034/j.1600-0641.2000.033004543.x · Cited by 143
Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis
Nakamura, K., Yoneda, M., Yokohama, S., Tamori, K., Sato, Y., Aso, K., Aoshima, M., Hasegawa, T., & MAKING, I. (1998) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1998.tb00674.x · Cited by 143
Oral budesonide for treatment of autoimmune chronic active hepatitis
Danielsson, A., & Prytz, H. (1994) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1994.tb00334.x · Cited by 142
Hofer, H., Oesterreicher, C., Wrba, F., Ferenci, P., & Penner, E. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.029348 · Cited by 140
The impact of ethnicity on the natural history of autoimmune hepatitis
Verma, S., Torbenson, M. S., & Thuluvath, P. J. (2007) · Hepatology · doi:10.1002/hep.21884 · Cited by 139
Czaja, A. J., Carpenter, H. A., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510300603 · Cited by 139
Evolution of autoimmune hepatitis to primary sclerosing cholangitis: A sequential syndrome
Abdo, A., Bain, V. G., Kichian, K., & Lee, S. S. (2002) · Hepatology · doi:10.1053/jhep.2002.37200 · Cited by 138
Efficacy of Tacrolimus in the Treatment of Steroid Refractory Autoimmune Hepatitis
Aqel, B. A., Machicao, V. I., Rosser, B. G., Satyanarayana, R., Harnois, D. M., & Dickson, R. C. (2004) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000139050.67178.be · Cited by 138
Prevalence and epidemiology of autoimmune hepatitis
Boberg, K. M. (2002) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00021-1 · Cited by 138
Czaja, A. J., Wolf, A. M., & Baggenstoss, A. H. (1981) · Gastroenterology · doi:10.1016/0016-5085(81)90126-8 · Cited by 137
Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis
Zauli, D., Ghetti, S., Grassi, A., Descovich, C., Cassani, F., Ballardini, G., Muratori, L., & Bianchi, F. B. (1997) · Hepatology · doi:10.1002/hep.510250510 · Cited by 136
Czaja, A. J., Souto, E. O., Bittencourt, P. L., Cançado, E. L. R., Porta, G., Goldberg, A. C., & Donaldson, P. T. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00182-4 · Cited by 136
Abdalian, R., Dhar, P., Jhaveri, K. S., Haider, M. A., Guindi, M. M., & Heathcote, J. (2008) · Hepatology · doi:10.1002/hep.22073 · Cited by 134
Stellon, A. J., Keating, J. J., Johnson, P. J., McFarlane, I. G., & Williams, R. L. (1988) · Hepatology · doi:10.1002/hep.1840080414 · Cited by 134
Yeoman, A. D., Westbrook, R., Zen, Y., Maninchedda, P., Portmann, B. C., Devlin, J., O’Grady, J. G., Harrison, P., & Heneghan, M. A. (2010) · Hepatology · doi:10.1002/hep.24141 · Cited by 133
Self-citationDrug-Associated Acute Pancreatitis: Twenty-One Years of Spontaneous Reporting in The Netherlands
Eland, I. A., van Puijenbroek, E., Sturkenboom, M., Wilson, J. H. P., & Stricker, B. H. C. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01367.x · Cited by 132
Cyclosporin A Is a Promising Alternative to Corticosteroids in Autoimmune Hepatitis
Malekzadeh, R., Nasseri‐Moghaddam, S., Kaviani, M. J., Taheri, H., Kamalian, N., & Sotoudeh, M. (2001) · Digestive Diseases and Sciences · doi:10.1023/a:1010683817344 · Cited by 131
Prognosis of Symptomatic Versus Asymptomatic Autoimmune Hepatitis
Kogan, J., Safadi, R., Ashur, Y., Shouval, D., & Ilan, Y. (2002) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200207000-00016 · Cited by 130
Autoantibodies and their Antigens in Autoimmune Hepatitis
Bogdanos, D. P., Mieli‐Vergani, G., & Vergani, D. (2009) · Seminars in Liver Disease · doi:10.1055/s-0029-1233533 · Cited by 129
Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis†
Czaja, A. J., & Carpenter, H. A. (2004) · Hepatology · doi:10.1002/hep.20235 · Cited by 128
Heneghan, M. A., Allan, M. L., Bornstein, J. D., Muir, A. J., & Tendler, D. A. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.011 · Cited by 128
Self-citationTalwalkar, J. A., Keach, J. C., Angulo, P., & Lindor, K. D. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05703.x · Cited by 127
Consequences of treatment withdrawal in type 1 autoimmune hepatitis
Montaño‐Loza, A. J., Carpenter, H. A., & Czaja, A. J. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01444.x · Cited by 126
Long-term follow-up of chronic active hepatitis of moderate severity.
de Groote, J., Fevery, J., & Lepoutre, L. (1978) · Gut · doi:10.1136/gut.19.6.510 · Cited by 125
Larsen, F. S. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i23.3232 · Cited by 124
Czaja, A. J., Ludwig, J., Baggenstoss, A. H., & Wolf, A. M. (1981) · New England Journal of Medicine · doi:10.1056/nejm198101013040102 · Cited by 124
Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis
Czaja, A. J., & Lindor, K. D. (2000) · Gastroenterology · doi:10.1053/gast.2000.0010000001 · Cited by 123
Aguilera, I., Wichmann, I., Sousa, J. M., Bernardos, A., Franco, E., García-Lozano, J.-R., & Núñez‐Roldán, A. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01682.x · Cited by 122
Czaja, A. J., Rakela, J. L., & Ludwig, J. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90503-3 · Cited by 120
Scully, L. J., Clarke, D., & Barr, R. J. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01316809 · Cited by 119
Czaja, A. J., Carpenter, H. A., Santrach, P. J., Moore, S. B., Taswell, H. F., & Homburger, H. A. (1993) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80279-x · Cited by 118
Rapidity of treatment response and outcome in type 1 autoimmune hepatitis
Czaja, A. J. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.02.026 · Cited by 117
Czaja, A. J., Carpenter, H. A., Santrach, P. J., & Moore, S. B. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80186-3 · Cited by 116
Epidemiology of autoimmune liver disease
FELD, J., & Heathcote, E. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.03165.x · Cited by 115
Duration of immunosuppressive therapy in autoimmune hepatitis
Kanzler, S., Gerken, G., Löhr, H. F., Galle, P. R., Büschenfelde, K. M. Z., & Lohse, A. W. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00095-7 · Cited by 115
Villalta, D., Girolami, D., Bidoli, E., Bizzaro, N., Tampoia, M., Liguori, M., Pradella, M., Tonutti, E., & Tozzoli, R. (2005) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.20047 · Cited by 114
The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis
Cooksley, W. G. E., Cooksley, E., Bradbear, R. A., Robinson, W., Harrison, M., Halliday, J. W., Powell, L. W., Ng, H.-S., Seah, C. S., Okuda, K., et al. (1986) · Hepatology · doi:10.1002/hep.1840060302 · Cited by 113
Efficacy of cyclosporin A in children with type 2 autoimmune hepatitis
Debray, D., Maggiore, G., Girardet, J.-P., Mallet, E., & Bernard, O. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70339-2 · Cited by 112
Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin
Zolfino, T., Heneghan, M. A., Norris, S., Harrison, P., Portmann, B. C., & McFarlane, I. G. (2002) · Gut · doi:10.1136/gut.50.5.713 · Cited by 111
Self-citationChatur, N., Ramji, A. S., Bain, V. G., Ma, M. M., Marotta, P. J., Ghent, C. N., Lilly, L., Heathcote, E. J., Deschênes, M., Lee, S. S., et al. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01107.x · Cited by 111
The nature and prognosis of severe cryptogenic chronic active hepatitis
Czaja, A. J., Carpenter, H. A., Santrach, P. J., Moore, S. B., & Homburger, H. A. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90656-w · Cited by 108
A Single Center Review of the Use of Mycophenolate Mofetil in the Treatment of Autoimmune Hepatitis
Hlivko, J. T., Shiffman, M. L., Stravitz, R. T., Luketic, V. A., Sanyal, A. J., Fuchs, M. A., & Sterling, R. K. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.04.006 · Cited by 107
Sherman, K. E., Narkewicz, M. R., & Pinto, P. C. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80615-4 · Cited by 106
Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients
Qiu, D., Wang, Q., Wang, H., Xie, Q., Zang, G., Jiang, H., Tu, C., Guo, J., Zhang, S., Wang, J., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.032 · Cited by 105
Devlin, S. M., Swain, M. G., Urbanski, S. J., & Burak, K. W. (2004) · Canadian Journal of Gastroenterology · doi:10.1155/2004/504591 · Cited by 105
Follow‐up of Children With Autoimmune Hepatitis Treated With Cyclosporine
Cuarterolo, M. L., Ciocca, M. E., Velasco, C. C., Ramonet, M., González, T., López, S. I., Garsd, A., & Álvarez, F. (2006) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000235975.75120.38 · Cited by 104
Lewin, M., Vilgrain, V., Ozenne, V., Lemoine, M., Wendum, D., Paradis, V., Ziol, M., Arrivé, L., Beaugrand, M., Poupon, R. Y., et al. (2009) · Hepatology · doi:10.1002/hep.23024 · Cited by 104
Budesonide in previously untreated autoimmune hepatitis
Wiegand, J., Schüler, A., Kanzler, S., Lohse, A. W., Beuers, U. H., Kreisel, W., Spengler, U., Koletzko, S., Jansen, P. L. M., Hochhaus, G., et al. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01122.x · Cited by 103
Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis
Jones, D. E. J., James, O., Portmann, B. C., Burt, A. D., Williams, R. L., & Hudson, M. (1999) · Hepatology · doi:10.1002/hep.510300103 · Cited by 102
Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis
Ballot, E., Homberg, J. C., & Johanet, C. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80361-x · Cited by 102
Predictive Factors for Hepatocellular Carcinoma in Type 1 Autoimmune Hepatitis
Montaño‐Loza, A. J., Carpenter, H. A., & Czaja, A. J. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01922.x · Cited by 101
The significance of autoantibodies and immunoglobulins in acute liver failure: A cohort study
Bernal, W. E., Ma, Y., Smith, H. M., Portmann, B. C., Wendon, J. A., & Vergani, D. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.05.011 · Cited by 101
Autoimmune hepatitis following hepatitis A virus infection
Huppertz, H., Triechel, U., Gassel, A. M., Jeschke, R., & Büschenfelde, K. M. Z. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80336-x · Cited by 100
Sharzehi, K., Huang, M. A., Schreibman, I. R., & Brown, K. (2010) · Canadian Journal of Gastroenterology · doi:10.1155/2010/891252 · Cited by 97
Drug-induced lupus-like syndrome associated with severe autoimmune hepatitis
Graziadei, I., Obermoser, G., Sepp, N. T., Erhart, K. H., & Vogel, W. (2003) · Lupus · doi:10.1191/0961203303lu313cr · Cited by 97
Features and consequences of untreated type 1 autoimmune hepatitis
Czaja, A. J. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01904.x · Cited by 97
Miyake, Y., Iwasaki, Y., Terada, R., Takagi, S., Okamaoto, R., Ikeda, H., Sakai, N., Makino, Y., Kobashi, H., Takaguchi, K., et al. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.06.006 · Cited by 97
Clinicopathological features of acute-onset autoimmune hepatitis
Okano, N., Yamamoto, K., Sakaguchi, K., Miyake, Y., Shimada, N., Hakoda, T., Terada, R., Baba, S., Suzuki, T., & Tsuji, T. (2003) · Hepatology Research · doi:10.1016/s1386-6346(02)00274-7 · Cited by 97
Czaja, A. J., & Carpenter, H. A. (2003) · Liver International · doi:10.1034/j.1600-0676.2003.00810.x · Cited by 97
Lüth, S., Kanzler, S., Frenzel, C., Kasper, H. U., Dienes, H. P., Schramm, C., Galle, P. R., Herkel, J., & Lohse, A. W. (2008) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318157c614 · Cited by 96
Kanzler, S., Gerken, G., Dienes, H. P., Büschenfelde, K. H. M. Z., & Lohse, A. (1997) · PubMed · Cited by 95
Hepatocellular Carcinoma inAutoimmune Hepatitis
Park, S. Z., Nagorney, D. M., & Czaja, A. J. (2000) · Digestive Diseases and Sciences · doi:10.1023/a:1005638500236 · Cited by 93
Treatment challenges and investigational opportunities in autoimmune hepatitis
Czaja, A. J., Bianchi, F. B., Carpenter, H. A., Krawitt, E. L., Lohse, A. W., Manns, M. P., McFarlane, I. G., Mieli‐Vergani, G., Toda, G., Vergani, D., et al. (2004) · Hepatology · doi:10.1002/hep.20539 · Cited by 92
Autoimmune hepatitis triggered by administration of an herbal medicine.
KAMIYAMA, T., Nouchi, T., Kojima, S., Murata, N., Ikeda, T., & Sato, C. (1997) · PubMed · Cited by 91
Severe chronic active liver disease
Schalm, S. W., Korman, M. G., Summerskill, W. H. J., Czaja, A. J., & Baggenstoss, A. H. (1977) · Digestive Diseases and Sciences · doi:10.1007/bf01076196 · Cited by 91
Type I autoimmune hepatitis: clinical course and outcome in an Italian multicentre study
Floreani, A., Niro, G. A., Rizzotto, E. R., ANTONIAZZI, S., Ferrara, F., Carderi, I., Baldo, V., Premoli, A., OLIVERO, F., MORELLO, E., et al. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03104.x · Cited by 90
Czaja, A. J., Beaver, S. J., & Shiels, M. T. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90862-6 · Cited by 89
Czaja, A. J., & Carpenter, H. A. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000177260.72692.e8 · Cited by 89
Successful treatment of refractory type 1 autoimmune hepatitis with methotrexate
Burak, K. W., Urbanski, S. J., & Swain, M. G. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80128-1 · Cited by 89
Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis
Czaja, A. J., Muratori, P., Muratori, L., Carpenter, H. A., & Bianchi, F. B. (2004) · Liver International · doi:10.1111/j.1478-3231.2004.0924.x · Cited by 89
Inductivo–Yu, I., Adams, A., Gish, R. G., Wakil, A. E., Bzowej, N. H., Frederick, R. T., & Bonacini, M. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.02.030 · Cited by 88
Gassert, D. J., Garcia, H., Tanaka, K., & Reinus, J. F. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9665-4 · Cited by 86
Werner, M., Wallerstedt, S., Lindgren, S. C., Almer, S. H., Björnsson, E., Bergquist, A. M., Prytz, H., Sandberg–Gertzén, H., Hultcrantz, R. W., Sangfelt, P., et al. (2010) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365520903555861 · Cited by 86
Is there a role for viruses in triggering autoimmune hepatitis?
Vento, S., & Cainelli, F. (2003) · Autoimmunity Reviews · doi:10.1016/s1568-9972(03)00053-3 · Cited by 86
Werner, M., Almer, S. H., Prytz, H., Lindgren, S. C., Wallerstedt, S., Bjornsson, E. S., Bergquist, A. M., Sandberg–Gertzén, H., Hultcrantz, R. W., Sangfelt, P., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.08.022 · Cited by 85
Davis, G. L., Czaja, A. J., & Ludwig, J. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90186-0 · Cited by 84
Antinuclear Antibodies and Patterns of Nuclear Immunofluorescence in Type 1 Autoimmune Hepatitis
Czaja, A. J., Cassani, F., Cataleta, M., Valentini, P., & Bianchi, F. B. (1997) · Digestive Diseases and Sciences · doi:10.1023/a:1018809431189 · Cited by 82
Clinical characteristics of fulminant‐type autoimmune hepatitis: an analysis of eleven cases
Miyake, Y., IWASAKI, Y., Terada, R., ONISHI, T., OKAMOTO, R., SAKAI, N., Sakaguchi, K., & Shiratori, Y. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02894.x · Cited by 82
A novel histological lesion in glucocorticoid-responsive chronic hepatitis
Pratt, D., Fawaz, K. A., Rabson, A. R., Dellelis, R., & Kaplan, M. M. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9247489 · Cited by 82
Minocycline as a Cause of Drug-Induced Autoimmune Hepatitis
Goldstein, N. S., Bayati, N., Silverman, A. L., & Gordon, S. C. (2000) · American Journal of Clinical Pathology · doi:10.1309/kv2j-vx6q-l95v-vde4 · Cited by 82
The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis
McFarlane, I. G. (1998) · Gut · doi:10.1136/gut.42.5.599 · Cited by 81
Gatselis, N., Zachou, K., Papamichalis, P. A., Koukoulis, G. Κ., Gabeta, S., Dalekos, G. N., & Rigopoulou, E. I. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.03.005 · Cited by 77
Incidencia y prevalencia de hepatitis autoinmune en el área sanitaria del Hospital de Sagunto
Primo, J., Merino, C., Fernández, J., Molés, J. R., Llorca, P. S., & Hinojosa, J. (2004) · Gastroenterología y Hepatología · doi:10.1016/s0210-5705(03)70452-x · Cited by 76
Adalimumab-induced Autoimmune Hepatitis
Adar, T., Mizrahi, M., Pappo, O., Elazary, A. S., & Shibolet, O. (2009) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181a745e7 · Cited by 76
Autoimmune hepatitis among fertile women: Strategies during pregnancy and breastfeeding?
Werner, M., Bjornsson, E. S., Prytz, H., Lindgren, S. C., Almer, S. H., Broomé, U., Wallerstedt, S., Sandberg–Gertzén, H., Hultcrantz, R. W., Sangfeldt, P., et al. (2007) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520601155266 · Cited by 75
Singh, R., Nair, S. P., Farr, G. H., Mason, A. L., & Perrillo, R. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.06052.x · Cited by 75
Thiopurine Methyltransferase Deficiency and Azathioprine Intolerance in Autoimmune Hepatitis
Czaja, A. J., & Carpenter, H. A. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9336-5 · Cited by 75
Autoimmune hepatitis: diagnostic criteria, subclassifications, and clinical features
McFarlane, I. G. (2002) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00019-3 · Cited by 74
Wang, K. K., Czaja, A. J., Beaver, S. J., & Go, V. L. W. (1989) · Hepatology · doi:10.1002/hep.1840100110 · Cited by 73
Cited by
Diagnosis and management of autoimmune hepatitis
Manns, M. P., Czaja, A. J., Gorham, J. D., Krawitt, E. L., Mieli-Vergani, G., Vergani, D., & Vierling, J. M. (2010) · Hepatology · doi:10.1002/hep.23584 · Cited by 1,442
EASL Clinical Practice Guidelines: autoimmune hepatitis
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.06.030 · Cited by 1,245
“Of note, in some patients with acute presentation of AIH, immunoglobulin G (IgG) levels may be within the normal range and antinuclear (ANA) and/or smooth muscle antibodies (SMA) as first screening may be negative and thus, the clinician may not consider AIH [3,4,34,40,41].”
BackgroundMethodInfluentialMack, C. L., Adams, D., Assis, D. N., Kerkar, N., Manns, M. P., Mayo, M. J., Vierling, J. M., Alsawas, M., Murad, M. H., & Czaja, A. J. (2020) · Hepatology · doi:10.1002/hep.31065 · Cited by 983
“(463) These risks justify surveillance strategies that include hepatic ultrasonography, with or without serum alphafetoprotein (AFP) level, every 6 months in patients with cirrhosis(466-468) and adherence to standard guidelines for detection of extrahepatic malignancy.”
BackgroundInfluentialHepatic inflammation and progressive liver fibrosis in chronic liver disease
Czaja, A. J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i10.2515 · Cited by 342
Evidence-based clinical practice guidelines for liver cirrhosis 2015
Fukui, H., Saito, H., Ueno, Y., Uto, H., Obara, K., Sakaida, I., Shibuya, A., Seike, M., Nagoshi, S., Segawa, M., et al. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1216-y · Cited by 306
Metadata
- Authors
- Gleeson, D., & Heneghan, M. A.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2011-07-13
- Volume
- 60
- Issue
- 12
- Pages
- 1611-1629
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2132205159
- Cited by
- 275
- References
- 261
- FWCI
- 8.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.